ArticleInternational journal of molecular sciences2021

NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.

Mandy Gruijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.